Target
Poly [ADP-ribose] polymerase 2
Ligand
BDBM50548674
Substrate
n/a
Meas. Tech.
ChEMBL_2022850 (CHEMBL4676663)
IC50
7.2±n/a nM
Citation
 Karche, NPBhonde, MSinha, NJana, GKukreja, GKurhade, SPJagdale, ARTilekar, ARHajare, AKJadhav, GRGupta, NRLimaye, RKhedkar, NThube, BRShaikh, JSRao Irlapati, NPhukan, SGole, GBommakanti, AKhanwalkar, HPawar, YKale, RKumar, RGupta, RPraveen Kumar, VRWahid, SFrancis, ABhat, TKamble, NPatil, VNigade, PBModi, DPawar, SNaidu, SVolam, HPagdala, VMallurwar, SGoyal, HBora, PAhirrao, PSingh, MKamalakannan, PNaik, KRKumar, PPowar, RGShankar, RBBernstein, PRGundu, JNemmani, KNarasimham, LGeorge, KSSharma, SBakhle, DKamboj, RKPalle, VP Discovery of isoquinolinone and naphthyridinone-based inhibitors of poly(ADP-ribose) polymerase-1 (PARP1) as anticancer agents: Structure activity relationship and preclinical characterization. Bioorg Med Chem 28:0 (2020) [PubMed]  Article
Target
Name:
Poly [ADP-ribose] polymerase 2
Synonyms:
(ARTD2 or PARP2) | ADPRT2 | ADPRTL2 | PARP2 | PARP2_HUMAN | Poly [ADP-ribose] polymerase 2 (PARP-2) | Poly [ADP-ribose] polymerase 2 (PARP2)
Type:
Enzyme
Mol. Mass.:
66225.70
Organism:
Homo sapiens (Human)
Description:
Q9UGN5
Residue:
583
Sequence:
MAARRRRSTGGGRARALNESKRVNNGNTAPEDSSPAKKTRRCQRQESKKMPVAGGKANKDRTEDKQDGMPGRSWASKRVSESVKALLLKGKAPVDPECTAKVGKAHVYCEGNDVYDVMLNQTNLQFNNNKYYLIQLLEDDAQRNFSVWMRWGRVGKMGQHSLVACSGNLNKAKEIFQKKFLDKTKNNWEDREKFEKVPGKYDMLQMDYATNTQDEEETKKEESLKSPLKPESQLDLRVQELIKLICNVQAMEEMMMEMKYNTKKAPLGKLTVAQIKAGYQSLKKIEDCIRAGQHGRALMEACNEFYTRIPHDFGLRTPPLIRTQKELSEKIQLLEALGDIEIAIKLVKTELQSPEHPLDQHYRNLHCALRPLDHESYEFKVISQYLQSTHAPTHSDYTMTLLDLFEVEKDGEKEAFREDLHNRMLLWHGSRMSNWVGILSHGLRIAPPEAPITGYMFGKGIYFADMSSKSANYCFASRLKNTGLLLLSEVALGQCNELLEANPKAEGLLQGKHSTKGLGKMAPSSAHFVTLNGSTVPLGPASDTGILNPDGYTLNYNEYIVYNPNQVRMRYLLKVQFNFLQLW
  
Inhibitor
Name:
BDBM50548674
Synonyms:
CHEMBL4787850
Type:
Small organic molecule
Emp. Form.:
C23H25N5O
Mol. Mass.:
387.4775
SMILES:
Nc1cccc2c1cc(CCCN1CCN(CC1)c1ccc(cc1)C#N)[nH]c2=O
Structure:
Search PDB for entries with ligand similarity: